A next-generation specialty pharmaceuticals company

Technology Platform

Liposeuticals is a next-generation specialty pharma company with a proprietary approach to reformulating sterile injectable drugs.

Market Niche

The addressable market opportunity in the US for the company's sterile injectables portfolio is estimated to be $7 billion annually.

Therapeutic Focus

Liposeuticals is focusing on the development of proprietary products in the fields of anesthesiology, oncology and infectious disease.